Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Evidence at Time of Regulatory Approval and Cost of New Antibiotics in 2016-19: Cohort Study of FDA Approved Drugs
HOME
/
Research Publications
/
Evidence at Time of Regulatory Approval and Cost of New Antibiotics in 2016-19: Cohort Study of FDA Approved Drugs